loading...

EORTC Quality of Life Questionnaire - Bone Metastases Module (EORTC QLQ-BM22)

EORTC Quality of Life Group

ProQolid

Basic description

  • Developed in 2008
  • An Item Library was created and offer the possibility to add items from other module(s)

EORTC: European Organization for Research and Treatment of Cancer

Authors

EORTC Quality of Life Group

Copyright
© Copyright 2008 EORTC Quality of Life Group. All rights reserved.
Objective
To supplement the EORTC QLQ-C30 or QLQ-C15 measures with a module questionnaire specific to patients with bone metastases
Therapeutic area
  • Neoplasms
Therapeutic indication

Generic for Neoplasms

Bone metastases
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English
Translations
22 translation(s)
Bibliographic reference(s) of the original questionnaire

Chow E, Hird A, Velikova G, et al; EORTC Quality of Life Group; Collaboration for Cancer Outcomes Research and Evaluation. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer. 2009 May;45(7):1146-52 (PubMed Abstract)

Chow E, Nguyen J, Zhang L, et al.; European Organization for Research Treatment of Cancer Quality of Life Group. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer. 2012 Mar 1;118(5):1457-65 (PubMed Abstract)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us